--2025/Q1-- / 13.466B--
--2024/Q4-- / 13.998B--
Oct 30, 20242024/Q311.439B / 12.119B--
Apr 30, 20242024/Q18.768B / 8.930B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 743.590
- -9.820-1.30%
Trading Nov 21 12:02 ET
705.90BMarket Cap80.39P/E (TTM)
746.120High735.000Low1.72MVolume746.490Open753.410Pre Close1.28BTurnover0.18%Turnover Ratio128.21P/E (Static)949.32MShares970.91652wk High49.57P/B704.37BFloat Cap557.99452wk Low5.03Dividend TTM947.25MShs Float970.916Historical High0.68%Div YieldTTM1.48%Amplitude5.278Historical Low741.737Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q3 2024 Earnings Date
Overview | Lilly reported revenue of $11.4 billion, a 20% year-over-year increase, along with earnings per share (EPS) of $1.18, which fell short of Wall Street estimates
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 12.12B | 11.44B | -679.50M |
| Miss Est. | +27.58% | +20.43% | -5.61% |
| EPS | 1.54 | 1.07 | -0.47 |
| Miss Est. | +2677.80% | +1883.33% | -30.70% |
Analyst Rating
Nov 18, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
